Hims & Hers GLP-1 review (2026): what changed after Novo, and who it's right for

What Hims & Hers is, and what changed in March 2026

Hims & Hers is one of the largest telehealth companies in the US. It is listed on the New York Stock Exchange. It is best known for men's hair loss and ED treatments. Weight loss is now a major part of its business, sold to women under the Hers brand.

Through 2024 and 2025, that program ran on compounded semaglutide. Compounded means a pharmacy mixes its own version of a drug. Semaglutide is the medicine in Ozempic and Wegovy. The pharmacy copies cost far less than the brand names.

That changed on March 9, 2026. Hims reached a deal with Novo Nordisk, the maker of Wegovy. Novo then dropped its patent lawsuit. Hims stopped advertising compounded GLP-1s. It now offers them only on a limited scale, when a clinician decides a patient needs one.

Its main lineup is now brand-name and FDA-approved: Wegovy, Ozempic, Zepbound and Foundayo.

What Hims offers in 2026, and what it costs

Each price below is for the medicine alone. The membership is billed on top. Here is the quick pick:

• Cheapest start: the Wegovy pill or Foundayo.
• A weekly shot for weight loss: the Wegovy pen.
• The strongest average result: Zepbound.
• If you have type 2 diabetes: Ozempic, as a pen or a pill.
• If your insurance covers the drug: a maker's savings card, explained below.

• Wegovy pill: about $300/mo at the usual doses · First month about $150 · About $200 at the 4 mg step
• Wegovy pen: about $350/mo at every standard dose · About $200 for each of the first 2 fills, an offer that runs through Dec 31, 2026 · About $400 at the high 7.2 mg dose, sold as Wegovy HD
• Zepbound vial or KwikPen: about $450/mo from 7.5 mg up · About $300 at the 2.5 mg start · About $400 at 5 mg · The $450 price needs each refill within 45 days, or it rises to about $500–$700
• Ozempic pen: about $350/mo up to 1 mg · About $200 for each of the first 2 fills · About $500 at 2 mg
• Ozempic pill: from about $150/mo
• Foundayo pill: from about $150/mo
• Mounjaro or single-dose Zepbound pens: about $1,900/mo, the full retail price. Few people have a reason to pay it.

The membership catches people off guard. New members pay $39 for the first month. It then renews at about $150 a month, whatever medicine you take. It covers the online consultation, your prescriptions, messaging with the care team and a smart scale. It does not cover the medicine.

You can claim the medicine from an HSA or FSA, the tax-free health accounts many employers offer. The membership does not qualify. Our Hims cost page breaks down every line.

Can insurance lower the price?

Hims sells at cash prices and does not ask about insurance. Still, a commercial plan can help. Commercial means a plan from your employer or one you buy yourself.

If that plan covers Wegovy or Zepbound, the maker's savings card can bring the drug to as little as $25 a month. The card's savings are capped at $100 a month. It works at a pharmacy that bills your plan, and the Hims membership still applies.

Medicare, Medicaid and other government plans can't use these cards. Our GLP-1 savings guide covers the Medicare route.

What Hims costs per year

Count the dose steps and the membership. A year runs about $5,000 to $6,850 all-in.

• Wegovy pill, climbing to the top dose: about $5,000 a year
• Wegovy pen: about $5,550 a year
• Zepbound, with every refill on time: about $6,850 a year
• Membership alone: about $1,680 a year
• With covered insurance and a savings card: about $2,000 a year, mostly the membership

The insurance route is by far the best deal. It needs a commercial plan that covers your drug, and you must qualify for the maker's savings offer.

Wegovy pill, Wegovy pen or Zepbound: which one is right for you?

Most women at Hims weigh these three. All are brand-name and FDA-approved, but they are not interchangeable. Two are the same medicine in different forms. The third is a different, newer medicine.

Wegovy pill: for women who won't inject

This is semaglutide, the same medicine as the Wegovy and Ozempic pens, in a daily tablet. It was the first GLP-1 pill the FDA approved for weight loss. The appeal is simple: no needle.

The trade-offs are real. You take it every day, on an empty stomach, with strict timing. Its average weight loss in trials was a little lower than the shot's. It suits a woman who wants a brand-name option and won't do injections.

Wegovy pen: the proven standard

This is the original once-weekly semaglutide pen. It is the most studied of the three for weight, with years of real-world use. Its side effects are well understood. It suits a woman who wants the established option and prefers one shot a week to a daily pill.

Zepbound: for the strongest result

Zepbound is tirzepatide, a newer weekly shot. It acts on two gut hormones, GIP and GLP-1, instead of one. In the head-to-head SURMOUNT-5 trial, tirzepatide led to more average weight loss than semaglutide.

That trial came before the higher 7.2 mg Wegovy dose was approved in March 2026. The new dose has narrowed the gap, and Hims sells it as Wegovy HD. Zepbound also costs the most of the three. It suits a woman whose priority is the biggest result and who can absorb the cost.

Like any GLP-1, it starts at a low dose and steps up. That keeps side effects manageable.

Ozempic and Foundayo: the other options

The Ozempic pen and the Ozempic pill are semaglutide too. They are approved for type 2 diabetes, not weight loss. They make sense mainly if you have type 2 diabetes.

Foundayo is orforglipron, a daily GLP-1 pill from Lilly. It is a different medicine from semaglutide. It is the other pill approved for weight loss, a choice for women who want a pill but not the Wegovy tablet.

How Hims works: an online form, and no appointment in most states

Hims runs mostly asynchronous care. That means no live appointment in most cases. You fill out a health questionnaire online. A licensed clinician reviews it and decides whether a GLP-1 suits you. If it does, the medicine ships to your home.

Some states require a video or audio visit first. Hims sets it up when it is needed. After that, you reach your care team by message in the app, at any hour. Dose changes are requested there too.

GLP-1s are not yet offered in every state. The questionnaire tells you if yours is covered.

This is the fastest, easiest way to start a GLP-1. It works best when your health is simple. If you have a complex history or take several medicines, a clinician who checks in with you is worth more.

Is Hims a good fit for perimenopause weight gain?

Perimenopause weight gain has a hormonal side. Falling estrogen lowers insulin sensitivity, which is how well your body uses insulin to handle sugar. It also moves fat toward the belly. A clinician who understands that may treat you differently than one treating weight alone.

Hims & Hers does prescribe hormone therapy, through its Hers menopause line launched in 2025. It offers estradiol, the main form of estrogen, as a pill, patch or vaginal cream. It also offers progesterone. That care is not available in every state.

Our Hers review covers that service. It runs separately from the weight program, which is not built around menopause.

That doesn't stop Hims from helping with weight. GLP-1 medicines work whether or not the prescriber knows your hormone status. But you may want HRT and a GLP-1 discussed together, with menopause in mind. Then Alloy or Midi Health fit better.

What Hims reviews say

On Trustpilot, Hims scores 2.9 out of 5 from about 9,500 reviews. Those cover all its products, not only weight loss.

Reviews of the weight program reflect the async model: quick to start, less steady on follow-through. The most common praise is speed, with no appointments needed. The most common complaint is billing. Many users find out after signing up that the membership and the medicine are charged separately.

Cancelling works the same way. Stopping the medicine does not stop the membership. Cancelling the membership also ends your medicine plan. If you leave, cancel both and keep proof.

Most reviews online still describe the compounded era of 2024 and 2025, a different product. Give recent reviews more weight.